论文部分内容阅读
目的:通过本研究探讨小剂量米索前列醇联合缩宫素在孕足月引产中的临床效果。方法:研究对象选取海西州人民医院2013年-2014年期间收治的240例足月引产孕妇,将入选对象随机分为观察组(140例)与对照组(100)例,观察组给予小剂量米索前列醇联合缩宫素引产,对照组仅给予催产素引产。结果:两组引产成功率比较,观察组(94.3%)明显优于对照组(77.0%),两组间差异显著(P<0.05)。结论:使用小剂量米索前列醇联合缩宫素疗效可靠,成功率明显高于以往单纯使用缩宫素引产,且药物安全、有效,可明显降低剖宫产手术率。
OBJECTIVE: To investigate the clinical effect of low-dose misoprostol combined with oxytocin on pregnancy-induced abortion in this study. Methods: Two hundred and forty full-term pregnant women were enrolled from Haixi People’s Hospital from 2013 to 2014. The selected subjects were randomly divided into observation group (140 cases) and control group (100 cases). The observation group was given low dose Misoprostol combined oxytocin induced labor, the control group only given oxytocin induction. Results: Compared with the control group (94.0%), the success rate of induction of labor in the two groups was significantly higher than that of the control group (77.0%), the difference was significant (P <0.05). Conclusion: The use of low-dose misoprostol combined with oxytocin is reliable, the success rate was significantly higher than the previous use of oxytocin alone, and the drug is safe and effective, can significantly reduce the caesarean section rate.